» Articles » PMID: 16553952

Psychometric Properties of Two Measures of Psychological Well-being in Adult Growth Hormone Deficiency

Overview
Publisher Biomed Central
Specialty Public Health
Date 2006 Mar 24
PMID 16553952
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Psychometric properties of two measures of psychological well-being were evaluated for adults with growth hormone deficiency (GHD): the General Well-being Index, (GWBI)--British version of the Psychological General Well-being Index, and the 12-item Well-being Questionnaire (W-BQ12).

Methods: Reliability, structure and other aspects of validity were investigated in a cross-sectional study of 157 adults with treated or untreated GHD, and sensitivity to change in a randomised placebo-controlled study of three months' growth hormone (GH) withdrawal from 12 of 21 GH-treated adults.

Results: Very high completion rates were evidence that both questionnaires were acceptable to respondents. Factor analyses did not indicate the existence of useful GWBI subscales, but confirmed the validity of calculating a GWBI Total score. However, very high internal consistency reliability (Cronbach's alpha = 0.96, N = 152), probably indicated some item redundancy in the 22-item GWBI. On the other hand, factor analyses confirmed the validity of the three W-BQ12 subscales of Negative Well-being, Energy, and Positive Well-being, each having excellent internal reliability (alphas of 0.86, 0.86 and 0.88, respectively, N from 152 to 154). There was no sign of item redundancy in the highly acceptable Cronbach's alpha of 0.93 (N = 148) for the whole W-BQ12 scale. Whilst neither questionnaire found significant differences between GH-treated and non-GH-treated patients, there were correlations (for GH-treated patients) with duration of GH treatment for GWBI Total (r = -0.36, p = 0.001, N = 85), W-BQ12 Total (r = 0.35, p = 0.001, N = 88) and for all W-BQ12 subscales: thus the longer the duration of GH treatment (ranging from 0.5 to 10 years), the better the well-being. Both questionnaires found that men had significantly better overall well-being than women. The W-BQ12 was more sensitive to change than the GWBI in the GH-Withdrawal study. A significant between-group difference in change in W-BQ12 Energy scores was found [t(18) = 3.25, p = 0.004, 2-tailed]: patients withdrawn from GH had reduced energy at end-point. The GWBI found no significant change.

Conclusion: The W-BQ12 is recommended in preference to the GWBI to measure well-being in adult GHD: it is considerably shorter, has three useful subscales, and has greater sensitivity to change.

Citing Articles

Influence of Baseline Psychological Health on Muscle Pain During Atorvastatin Treatment.

Zaleski A, Taylor B, Pescatello L, Dornelas E, White C, Thompson P J Cardiovasc Nurs. 2016; 32(6):544-550.

PMID: 27870723 PMC: 6083859. DOI: 10.1097/JCN.0000000000000382.


Access to Transplantation and Transplant Outcome Measures (ATTOM): study protocol of a UK wide, in-depth, prospective cohort analysis.

Oniscu G, Ravanan R, Wu D, Gibbons A, Li B, Tomson C BMJ Open. 2016; 6(2):e010377.

PMID: 26916695 PMC: 4769394. DOI: 10.1136/bmjopen-2015-010377.


Design, construction, and implementation of an online platform for patients with type 1 diabetes: EncoDiab.

Alvarado-Martel D, Canas F, Velasco R, Alcubierre N, Lopez-Rios L, Rius F Patient Prefer Adherence. 2015; 9:767-75.

PMID: 26124644 PMC: 4476477. DOI: 10.2147/PPA.S77730.


Psychological well-being of gynecologic and obstetric patients: a validation of the 12-item Well-Being Questionnaire (W-BQ12).

Watrowski R, Rohde A Wien Klin Wochenschr. 2014; 126(17-18):524-31.

PMID: 24993305 DOI: 10.1007/s00508-014-0569-6.


Quality of life in age-related macular degeneration: a review of the literature.

Mitchell J, Bradley C Health Qual Life Outcomes. 2006; 4:97.

PMID: 17184527 PMC: 1780057. DOI: 10.1186/1477-7525-4-97.


References
1.
Powrie J, WEISSBERGER A, Sonksen P . Growth hormone replacement therapy for growth hormone-deficient adults. Drugs. 1995; 49(5):656-63. DOI: 10.2165/00003495-199549050-00002. View

2.
Hunt S, McKenna S, Doward L . Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency. Acta Endocrinol (Copenh). 1993; 128 Suppl 2:37-40. View

3.
Wallymahmed M, Baker G, Humphris G, Dewey M, MacFarlane I . The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency. Clin Endocrinol (Oxf). 1996; 44(4):403-11. DOI: 10.1046/j.1365-2265.1996.704523.x. View

4.
Hopton J, Hunt S, Shiels C, Smith C . Measuring psychological well-being. The adapted General Well-Being Index in a primary care setting: a test of validity. Fam Pract. 1995; 12(4):452-60. DOI: 10.1093/fampra/12.4.452. View

5.
Carroll P, Littlewood R, Weissberger A, Bogalho P, McGauley G, Sonksen P . The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults. Eur J Endocrinol. 1997; 137(2):146-53. DOI: 10.1530/eje.0.1370146. View